Cognitive Neuroscience Market Segmentation:
Component Segment Analysis
The software segment in the cognitive neuroscience market is projected to account for the highest share of 40.5% by the end of 2035. The segment’s growth is highly attributed to an increase in the implementation of cloud-based neuroinformatics, machine learning algorithms, and AI-based neuroimaging analytics. For instance, tools, such as EEG and fMRI analytical software, are able to diminish interpretation time, thus suitable for use during diagnosis. In addition, drug discovery and administrative support are other notable factors that are also driving the segment’s upliftment. In this regard, pharma organizations have leveraged neural decoding software with the intention of escalating clinical studies.
Technology Segment Analysis
The fMRI systems segment in the cognitive neuroscience market is expected to hold the second-highest share of 30.7% during the forecast timeline. The segment’s development is fueled by the capability to effectively map out different areas of the brain and keep track of the blood activity and flow. As per a report published by the NLM in June 2023, ADHD is one of the most common neurological disorders, and an estimated 5% of adults and 9% of children are severely affected globally. Therefore, with the use of fMRI systems, it has become feasible to investigate connectivity patterns and brain activity, with the potential to aid and ensure appropriate diagnosis.
Application Segment Analysis
The clinical diagnostics segment in the cognitive neuroscience market is predicted to garner the third-largest share of 28.5% by the end of the forecast period. The segment caters to a multifaceted approach to recognize potential psychiatric or neurological conditions by accessing cognitive functions. As per a report published by the NLM in July 2023, 68% of individuals in the global population achieve an intelligence quotient (IQ) of 100, with a difference of more or less 15 points, denoting an essential aspect during clinical diagnosis. In addition, 95% of individuals fall in the range within 30 points of 100, thus constituting between 70 and 130. Besides, an IQ below 70 is regarded to be pathological and comprises intellectual disability, which is a huge part of the cognitive neuroscience market internationally.
Our in-depth analysis of the global cognitive neuroscience market includes the following segments:
|
Segment |
Subsegments |
|
Component |
|
|
Technology |
|
|
Application |
|
|
End user |
|
|
Disease Type |
|
|
Source |
|
